Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Researchers at Columbia University Irving Medical Center in the US have identified neutralising antibodies, isolated from Covid-19 patients, against the SARS-CoV-2 virus.
These antibodies are said to be among the most potent discovered to date and can be manufactured in vast quantities by pharmaceutical companies for the treatment of patients.
Researchers expect the antibodies to be particularly beneficial at early stages of the disease and to prevent infection, primarily in the elderly.
Columbia University Vagelos College of Physicians and Surgeons medicine professor David Ho said: “We now have a collection of antibodies.